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Functional foods containing bioactive compounds of whey may play an important role in prevention and treatment of obesity.
The aim of this study was to investigate the prospects of the biotechnological process of coacervation of whey proteins (CWP) in
chitosan and test its antiobesogenic potential.Methods. CWP (100mg⋅kg⋅day) was administered in mice with diet-induced obesity
for 8 weeks. The animals were divided into four groups: control normocaloric diet gavage with water (C) or coacervate (C-CWP),
and high fat diet gavage with water (HF) or coacervate (HF-CWP). Results.HF-CWP reduced weight gain and serum lipid fractions
and displayed reduced adiposity and insulin. Adiponectin was significantly higher in HF-CWP group when compared to the HF.
The level of LPS in HF-W group was significantly higher when compared to HF-CWP. The IL-10 showed an inverse correlation
between the levels of insulin and glucose in the mesenteric adipose tissue in the HF-CWP group. CWP promoted an increase in
both phosphorylation AMPK and the amount of ATGL in the mesenteric adipose tissue in HF-CWP group. Conclusion. CWP was
able to modulate effects, possibly due to its high biological value of proteins. We observed a protective effect against obesity and
improved the inflammatory milieu of white adipose tissue.
1. Introduction
Over the past decades, the incidence of obesity in the
population has increased severely, and it has become a public
health challenge. Its etiology is multifactorial, encompass-
ing environmental, dietary, physical inactivity, and genetic
factors. Obesity is a complex disease associated with a
high-calorie diet, which contributes to the development
of several other chronic noncommunicable diseases [1].
Obesity is also associated with increased plasma endotoxin
(lipopolysaccharide-LPS), saturated fatty acids [2, 3], and
proinflammatory cytokines [3] all intricately involved in
the development of comorbidities such as diabetes mellitus,
hypertension, dyslipidemia, and metabolic syndrome.
The fat tissue is not merely an energy storage organ, as
it plays crucial endocrine and immune roles. White adipose
tissue (WAT) is an endocrine organ secreting pro- and
anti-inflammatory adipokines such as tumor necrosis factor
alpha (TNF-𝛼) and interleukin-6 (IL-6), which are impor-
tant inflammatory markers that stimulate the production of
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several proteins and proinflammatory cytokines in different
cell types, via nuclear factor 𝜅B activation (NF-𝜅B) [4]. In
addition, endotoxin and saturated fatty acids act in the same
pathway of NF-𝜅B activation. Many studies have shown that
LPS (endotoxin) can activate these proteins in adipocytes,
thereby increasing the gene expression of proinflammatory
adipokines [5–7].
The main role of adipose lipolytic enzymes is to provide
other tissues with FAs in case of energy demand. Triglyceride
stored in the lipid droplet is first hydrolyzed by the adipose
triglyceride lipase enzyme (ATGL), also known as desnutrin,
releasing a diacylglycerol moiety and FA, which requires an
abhydrolase domain containing 5 (ABHD-5) promoter to be
activated. After hydrolysis by ATGL, diacylglycerols are then
hydrolyzed sequentially by hormone-sensitive lipase (HSL)
and monoglyceride lipase (MGL), producing nonesterified
fatty acids (NEFAs) and glycerol [8]. Different lipases gain
access to the lipid droplet when the proteins coating the
vesicle (perilipins) are phosphorylated. Perilipin A normally
prevents lipolysis of triglyceride by surrounding the lipid
droplet, thus preventing the access of lipases.
Whey protein (WP) has been found to be an excellent
prophylactic against obesity, because of the high biological
value mediated by bioactive peptides. These act as antimi-
crobial agents, antihypertensive, and regulators of immune
function, reducing body fat as well as a variety of related
beneficial mechanisms for human health. They also have
additional functions; for example, they have appetite sup-
pressant effects [9], stimulate muscle protein synthesis, and
regulate of body energy homeostasis [10]. There is plenty
of evidence indicating the potential of the WP in anti-
inflammatory and antioxidant effects of exercise [9, 11–13].
Chitosan complex coacervation with WP is composed of
by-products from the processing of shrimp, crab (chitosan),
and cheese, adding an environmental benefit to the product,
as these by-products may be reused and not disposed of in
landfill sites or released into rivers by producers [14]. In view
of the above, together with the development of fractionation
technique and whey protein preservation, employing the
method may contribute to the recovery of this valuable
nutrient and increase the expression of the functional prop-
erties [15]. Complex coacervation is defined as a colloidal
separation forming two liquid phases. This process is essen-
tially driven by attractive forces with opposite charges of
a biopolymer. This phenomenon occurs by the formation
of a system of balance between colloids and the diluted
supernatant [16, 17]. Thus, the purpose of the present study
was to investigate the prospect of a biotechnological process
of complexation and separation of cheese whey proteins in
chitosan and test their antiobesogenic potential through the
modulation of inflammatory markers and lipolytic pathway
present in obesity.
2. Methods
2.1. Coacervation and Characterization. In this study we
used sweet cheese whey (SW 1108 bag 25 kg) with 1.5% fat
marketed byCompanyAlibra-PR.Dissolving 10 g of thewhey
powder in 100mL of distilled water. Chitosan was used for
the coacervation medium molar mass with 75–85% degree
of deacetylation and viscosity of 200–800 cps (Sigma-Aldrich
44887-7). A concentration of 0.75mg/mL of Chitosan was
used. Chitosan was dissolved in citric acid (208mmol/L) and,
after this step, added to the cheese whey in a proportion of
1 : 1 under stirring at room temperature for 1 h. The pH of the
solution of chitosan and WP was adjusted to 6 with NaOH
(250mmol/L) and solubilized at room temperature (±25∘C)
with stirring. Solids coagulated with chitosan known as
coacervate (CWP) were collected by centrifugation (1300 g).
In order to obtain on average 30% of the protein coac-
ervate 3 L cheese whey was used. Thus, samples of CWP
were obtained for their chemical analysis of total lipids, total
protein, and lactose. Finally, for measurements of samples
of mineral micronutrients, Ca, K, Mg, and P, of cheese
whey, CWP, and Chitosan, 100 𝜇g was subjected to an optical
emission spectrometer for inductively coupled plasma (ICP
OES, Perkin Elmer Optima 3000DV, Norwalk, CT, USA). To
determine the existing protein fractions in CWP the elec-
trophoretic profile with reducing buffer containing 62.5mM
Tris-HCl, 20% glycerol, 2% sodium dodecyl sulfate(SDS)
(10%), 5% 𝛽-mercaptoethanol, and bromophenol blue at pH
6.8 was performed.
2.2. Animals and Treatment. This study was approved by the
Research Ethics Committee of the Universidade Federalde
Sa˜o Paulo, Escola Paulista de Medicina (UNIFESPEPM),
as the search protocol number 0473/10. Experimental pro-
cedures are in accordance with Principles of Laboratory
Animal Care formulated by the National Institutes of Health
(National Institutes of Health Publication number 96-23,
revised 1996).
Forty-nine male Swiss mice twelve-week-old from
CEDEME (Centro de Desenvolvimento de Modelos
Experimentais da Universidade Federal de Sa˜o Paulo) were
housed five in a cage in a standard experimental animal
laboratory and kept under controlled conditions of light
(12 h light-dark cycle with lights on at 6 am) and temperature
(24 ± 1∘C). All mice received water and food ad libitum.
The animals were divided as follows: control diet plus tap
water (C-W); control diet plus coacervate (C-CWP); high
fat diet plus coacervate (HF-CWP); and high fat diet plus
tap water (HF-W). All diets were prepared according to the
recommendations of the American Institute of Nutrition [18]
(Table 1). Coacervate (CWP) containing 100mg⋅kg⋅day was
given by gavage. The body weight gain was recorded twice a
week.
2.3. Composition and Aspect of the Coacervate. Figure 1(a)
shows the protein profile of the coacervate by the presence
of the major proteins of larger fractions, namely, alpha-
lactalbumin (𝛼-La-14 kDa), beta-lactoglobulin (𝛽-Lg—
18 kDa monomer and 34 kDa dimer form), bovine serum
albumin (BSA—66 kD), and lactoferrin (Lacf—86 kDa). The
CWP has a flocculation aspect (Figure 1(b)) consisting of
proteins and micronutrients such as calcium, potassium,
magnesium, phosphorus, and sodium (Table 2).
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Table 1: Composition of the control diet and diet enriched with saturated fatty acids according to AIN-93. Coacervate was resuspended in
300 𝜇L of water.
Components (%) Control diet (C) High fat diet (HF)
Corn starch 72.07 40.87
Casein 14.0 14.0
Soybean oil 4.0 4.0
Lard — 31.2
Cellulose 5.0 5.0
Vitamin mix 1.0 1.0
Mineral mix 3.5 3.5
L-cystine 0.18 0.18
Choline bitartrate 0.25 0.25
Butyl hydroquinone. g/kg 0.008 0.008
Energy. kcal/kg 3,802.8 5,362.8
Treatment by gavage
Coacervate (CWP) (C-CWP) 100mg⋅kg⋅day (HF-CWP) 100mg⋅kg⋅day
Water (W) (C-W) 300 𝜇L⋅day (HF-W) 300 𝜇L⋅day
Fatty acids (%)
Saturated (SFA) 17.12 34.13
Monounsaturated (MUFA) 25.63 39.14
Polyunsaturated (PUFA) 57.25 26.67
PUFA n3 4.32 6.37
PUFA n6 52.65 19.98
ST CWP
Lacfr
BSA
75
50
37
25
20
15 𝛼-La
𝛽-Lg monomer
𝛽-Lg dimer
(a) (b)
Figure 1: (a) Electrophoretic profile coacervate using 0.75mg/ml of chitosan. ST: standard of different molecular weights, 𝛼-La: alpha-
lactalbumin (14 kDa), 𝛽-Lg: beta-lactoglobulin monomer (18 kDa) and dimer (34 kDa), BSA: bovine albumin (66 kDa), and Lacfr: lactoferrin
(86 kDa). (b) Aspect of CWP proteins in Chitosan, freeze-dried.
2.4. Fatty Acids Composition of Diets. For total lipid extrac-
tion, diet samples were homogenized in chloroform and
methanol 2 : 1 (v/v), mixed, and incubated at room tem-
perature for 5min. Then, additional volumes of 1.25mL
chloroform and 1.25mL deionized H
2
O were added, and
finally, following being vigorously homogenized for 3min,
samples were centrifuged at 1000 rpm for 5min at room
temperature. The chloroform layer was dried under N
2
, and
the total extract was converted into methyl esters and was
analyzed in gas chromatography (GC), coupled with a flame
ionizer detector (FID), (Varian GC 3900) and fatty acid
profile was determined by calculating the retention time,
using a pattern of fatty acids with known retention time
(Supelco, 37 Components). The addition was initiated at a
temperature of 170∘C maintained for 1 minute and then a
ramp of 2.5∘C/min to a final temperature of 240∘C, which
was maintained for 5 minutes. The injector and detector
were maintained at 250∘C and 260∘C, respectively. We used a
column CP wax 52CB, with a thickness of 0.25mm, internal
diameter of 0.25 𝜇m, and length of 30m,with hydrogen as the
carrier gas at a linear velocity of 22 cm s−1.
2.5. Oral Glucose Tolerance Test (OGTT). After 12 hours
of fasting, blood was collected from the tail vein to assess
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Table 2: Partial composition of micronutrients by ICP and chemical macronutrients of CWP, WP, and Chitosan.
Nutritional composition
g/100 g
CWP WP Chitosan
Proteins 30 35 —
Lactose 1.7 40 —
Lipids 0.4 1.5 —
Ca 0.47 0.55 0.07
K 0.37 1.69 0.010
Mg 0.06 0.11 <0.001
P 0.46 0.53 0.003
Na 0.81 1.32 0.26
basal glucose concentration.Then, a glucose (Merck) solution
(1.4 g/kg) was administrated by gavage. Blood samples were
collected after 15, 30, 45, 60, and 120 minutes to measure
glucose concentration using a glucose analyzer (AccuCheck
Roche).
2.6. Experimental Procedures. At the end of the experimental
period, animals were fasted for 12 h overnight prior to
being sacrificed by decapitation. Trunk blood was collected
and immediately centrifuged (1125 g/15min at 4∘C). Serum
was separated and stored at −80∘C for later biochemical
and hormonal determination. The adipose tissue depots,
retroperitoneal (RET), mesenteric (MES), and epididymal
(EPI), were dissected, weighed, immediately frozen in liquid
nitrogen, and stored at −80∘C.
2.7. Biochemical and Hormonal Serum Analyses. Serum con-
centrations of glucose, total cholesterol, triglycerides, and
HDL-c were measured by an enzymatic colorimetric method
using commercial kits (Labtest, Brazil). Concentrations
of insulin and adiponectin were measured using specific
enzyme-linked immunosorbent assay (ELISA) kits (Milipore
and R&D Systems). LPS was determined using a commercial
kit (Lonza).
2.8. Mesenteric Adipose Tissue TNF-𝛼, IL-6, and IL-10 Protein
Level Determined by ELISA. Following euthanasia, mesen-
teric adipose tissuewas removed, homogenized into a specific
total protein extraction buffer [1% Triton X-100, 100mm
Tris-HCl (pH 7.4), 100mm sodium pyrophosphate, 100mm
sodium fluoride, 10mm EDTA, 10mm sodium orthovana-
date, 2.0mmphenylmethylsulfonyl fluoride, and 0.1mg apro-
tinin/mL], and centrifuged at 12,000 g for 30min at 4∘C.
The supernatant was saved, and the protein concentration
was determined using the BCA assay (Bio-Rad, Hercules,
California) with bovine serum albumin (BSA) as a reference.
Quantitative assessment of TNF-𝛼, IL-6, and IL-10 proteins
was carried out by ELISA (DuoSet ELISA, R&D Systems,
Minneapolis, MN) following the recommendations of the
manufacturer. All samples were run as duplicates and the
mean value was reported.
2.9. Protein Analysis by Western Blotting. After euthanasia,
themesenteric adipose tissuewas dissected andhomogenized
in 1.0mL of solubilization buffer at 4∘C [1% Triton X-100,
100mm Tris-HCl (pH 7.4), 100mm sodium pyrophosphate,
100mm sodium fluoride, 10mm EDTA, 10mm sodium
orthovanadate, 2.0mm phenylmethylsulfonyl fluoride, and
0.1mg aprotinin/mL]. Insoluble material was removed by
centrifugation for 30min at 9000 g in a 70 Ti rotor (Beckman,
Fullerton, CA, USA) at 4∘C. The protein concentration of
the supernatants was determined using the BCA assay (Bio-
Rad, Hercules, CA, USA). Proteins were denatured by boiling
(5min) in a Laemmli sample buffer containing 100mMDTT
and were run on 10% sodium dodecyl sulfate polyacrylamide
gel electrophoresis in a Bio-Rad miniature slab gel apparatus.
The proteins were electrotransferred from gels to nitro-
cellulose membranes for ∼1.30 h/4 gels at 15 V (constant) in
a Bio-Rad semidry transfer apparatus. Nonspecific protein
binding to the nitrocellulose was reduced by preincubation
for 2 h at 22∘C in blocking buffer (1% BSA, 10mM Tris,
150mM NaCl, and 0.02% Tween 20). The nitrocellulose
membranes were incubated overnight at 4∘C with antibodies
against hormone-sensitive lipase (HSL), adipose triglyceride
lipase (ATGL), abhydrolase domain containing protein 5
(ABHD-5), perilipin A, phospho 5󸀠 AMP-activated protein
kinase (p-AMPK𝛼 1 e 2 - Thr 172), and alpha-tubulin
obtained from Santa Cruz Biotechnology (Santa Cruz, CA,
USA) diluted 1 : 1000 with blocking buffer supplemented with
1% BSA and then washed for 30min in blocking buffer
without BSA. The blots were subsequently incubated with
peroxidase-conjugated secondary antibody for 1 h at 22∘C.
To evaluate protein loading, the membranes were stripped
and reblotted with an anti-alpha-tubulin antibody as appro-
priate. Specific bands were detected by chemiluminescence,
and visualization/capture was performed by UVITEC gel-
documentation system. Band intensities were quantified by
optical densitometry of developed autoradiographs (Scion
Image software, Scion Corporation, Frederick, MD, USA).
2.10. Statistical Analyses. All results are presented as mean
± standard error of the mean (SEM). Statistical significances
were assessed using two-way analysis of variance (ANOVA)
followed by Tukey’s post hoc analysis to identify significant
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Figure 2: Evolution of the average gain in body mass (g) of mice
for eight weeks of treatment with high fat diet (HF) or control
normocaloric (C) associated with gavage of coacervate (CWP) or
water (W). Data submitted with an average ± EPM. (b) C-W versus
HF-W and (d) HF-CWP versus HF-W. (𝑃 < 0.05).
differences among the groups. Pearson’s correlation was used
to assess the associations between the analyzed variables.
Differences were considered significant for (𝑃 ≤ 0.05) with
the StatsDirect software.
3. Results
3.1. Body and Tissue Weights. After six weeks of treatment,
the hyperlipidic diet promoted an increase in the body
weight when compared to the control (C-W versus HF-W).
On the other hand, HF-CWP showed a lower body weight
when compared to HF-W (Figure 2). The hyperlipid diet
increased the relative mass of epididymal and mesenteric
depot and adiposity (Σ of epididymal, retroperitoneal, and
mesenteric relative weight) when compared to control group
(C-W versus HF-W), while the association with coacervate
reduced these parameters (HF-W versus HF-CWP). The
retroperitoneal depot was increased in theHF-Wgroupwhen
compared to C-W one (Table 3).
3.2. Levels of Serum Lipids, Insulin, Adiponectin, Lipopolysac-
charides, and OGTT. The hyperlipid diet increased the
triacylglycerol (TAG) and VLDL when compared to con-
trol group (C-W versus HF-W), while the association with
coacervate reduced these parameters (HF-W versus HF-
CWP). Insulin level and HOMA index were increased in
the animals fed with hyperlipidic diet (C-W versus HF-
W). When associated with coacervate, the hyperlipid diet
promoted an increase in the adiponectin and a decrease in
LPS concentrations (HF-W versus HF-CWP) (Table 4).
The oral glucose tolerance test showed that the hyperli-
pidic diet promoted an increase at 15minutes when compared
to control (HF-W versus C-W). The AUC (area under
the curve) analysis increased HF-W compared with C-W
(Figure 3).
3.3. Concentration of IL-6, IL-10, and TNF-Alpha in the
Mesenteric Adipose Tissue. There was a significant decrease
100
10000
20000
30000
0
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140
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300
B 15 30 60 90 120
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dL
)
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b
b
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C-
W
C-
CW
P
H
F-
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P
H
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W
Figure 3: OGTT and AUC (area under the curve) after eight weeks
of treatment with high fat diet (HF) or normocaloric control (C)
associated with gavage of coacervate (CWP) or water (W). Glycemia
in time zero (basal-B), 15, 30, 60, 90, and 120 minutes after gavage of
0.2 g/100 g body weight of glucose. Data submitted with an average
± EPM. (b) C-W versus HF-W. (𝑃 < 0.05).
in IL-10 concentrations in the animal fed with high fat diet
when compared to animals fed the control diet (HF-W versus
C-W).The concentration of IL-6 in C-CWP group was lower
when compared to C-W group. The IL-10/TNF-𝛼 ratio in
mesenteric tissue showed no significant differences (Table 5).
3.4. Expression of Proteins Involved in Lipolysis Pathway.
Figures 4(a), 4(b), 4(c), 4(d), and 4(e) show the data of protein
expression of HSL, ATGL, Perilipin A, and ABHD-5 and
AMPK activity, respectively, in mesenteric adipose tissue.
HSL protein expressions were reduced in C-CWP and
HF-Wwhen compared to the C-Wgroup (Figure 4(a)).There
was an increase in ATGL in HF-CWP group when compared
to HF-W group (Figure 4(b)). Perilipin A was significantly
higher in the HF-W group when compared to the C-W
and HF-CWP groups (Figure 4(c)). There was a significant
decrease in the protein expression of ABDH-5 in C-CWP
when compared to C-W and HF-CWP groups (Figure 4(d)).
The phosphorylation of AMPK (Figure 4(e)) was higher in
HF-CWP compared to HF-W group.
3.5. Correlations. A positive correlation between AUC and
TAG (𝑟 = 0.86 𝑃 < 0.05) was found in the HF-W
group (Figure 5(a)). Figure 5(b) shows a positive correlation
between insulin levels and STA inHF-W(𝑟 = 0.96 𝑃 = 0.006)
group. Figures 5(c) and 5(d) show an inverse correlation
between insulin (𝑟 = −0.85 𝑃 = 0.02) (Figure 5(c)) and
glucose (𝑟 = −0.88 𝑃 = 0.01) levels with IL-10 in the
mesenteric adipose tissue in HF-CWP group (Figure 5(d)).
4. Discussion
Numerous procedures for isolation and recovery of WP
have been investigated and reported [19]. The functional,
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Figure 4: Protein expression of HSL (a); ATGL (b); perilipin A (c); ABHD-5 (d); and pAMPK (e) in the mesenteric adipose tissue. The data
are expressed in arbitrary units (A.U). Data submitted with an average ± EPM. (A) C-W versus C-CWP; (B) C-W versus HF-W; (C) C-CWP
versus HF-CWP; and (D) HF-CWP versus HF-W. (𝑃 < 0.05).
Table 3: Total mass (g), delta on the body mass gain (g/100 g body weight), and relative mass of tissue (RMT) (g/100 g body weight) of mice
treated with high fat diet (HF) or control normocaloric (C) associated with gavage of coacervate (CWP) or water (W).
C-W
(𝑛 = 10)
C-CWP
(𝑛 = 10)
HF-CWP
(𝑛 = 19)
HF-W
(𝑛 = 19)
RTM (g/100 g)
EPI
4.04 ± 0.17 3.52 ± 0.21 4.06 ± 0.28 4.93 ± 0.44
b,d
MES
1.80 ± 0.24 1.29 ± 0.21 1.72 ± 0.1 2.6 ± 0.36
b,d
RET
1.12 ± 0.10 0.82 ± 0.04 1.35 ± 0.12 1.48 ± 0.18
b
Σ adipose tissue
6.97 ± 0.38 5.64 ± 0.41 7.14 ± 0.46 9.02 ± 0.55
b,d
EPI: epididymal; MES: mesenteric; RET: retroperitoneal. Data submitted with an average ± EPM. bC-W versus HF-W and dHF-CWP versus HF-W. (𝑃 < 0.05).
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Figure 5: Continued.
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Figure 5: Correlation between different experimental groups: (a) TAG and AUC in different experimental groups. (b) Insulin and STA (sum
of adipose tissues MES, RET, and EPI). (c) Insulin and IL-10 of serum and mesenteric adipose tissue, respectively, and (d) glucose and IL-10
of serum and mesenteric adipose tissue, respectively.
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Table 4: Serum of triacylglycerol, total cholesterol, glucose, insulin, and adiponectin of mice treated with high fat diet (HF) or control
normocaloric (C) associated with gavage of coacervate (CWP) or water (W).
Serum measurements C-W(𝑛 = 10)
C-CWP
(𝑛 = 11)
HF-CWP
(𝑛 = 17)
HF-W
(𝑛 = 17)
Triacylglycerol (mg/dL)
133.37 ± 4.28 127.09 ± 4.85 129.30 ± 4.31 141.55 ± 3.94
b,d
Total cholesterol (mg/dL)
128.75 ± 4.22 129.46 ± 4.76 128.99 ± 3.35 150.03 ± 6.00
LDL (mg/dL)
68.81 ± 1.75 73.18 ± 3.07 75.66 ± 1.64 80.3 ± 3.28
VLDL (mg/dL)
26.32 ± 0.86 25.42 ± 0.97 25.86 ± 0.86 28.92 ± 0.76
b,d
HDL (mg/dL)
33.62 ± 1.75 36.71 ± 3.07 35.13 ± 1.64 40.83 ± 3.28
Glucose (mg/dL)
100.27 ± 2.69 89.84 ± 4.45 100.80 ± 3.58 105.28 ± 3.47
Insulin (ng/mL)
0.51 ± 0.03 0.64 ± 0.01 0.65 ± 0.01 0.75 ± 0.02
b
HOMA-IR
0.89 ± 0.26 0.97 ± 0.15 1.12 ± 0.21 1.25 ± 0.19
b
Adiponectin (ng/mL)
3.55 ± 0.47 3.98 ± 0.26 4.04 ± 0.10 3.34 ± 0.29
d
Lipopolysaccharides (EU/mL)
2.58 ± 0.98 1.61 ± 0.66 1.49 ± 0.50 3.07 ± 0.97
d
Data submitted with an average ± EPM. bC-W versus HF-W and dHF-CWP versus HF-W. (𝑃 < 0.05).
Table 5: Concentrations of IL-6, TNF-𝛼, IL-10, and IL-10/TNF-𝛼 (pg/mg of total protein content) in different experimental groups.
C-W
(𝑛 = 6)
C-CWP
(𝑛 = 7)
HF-CWP
(𝑛 = 12)
HF-W
(𝑛 = 12)
IL-6
329.69 ± 43.64 132.08 ± 24.10
a
215.80 ± 49.70 241.61 ± 29.27
TNF-𝛼
111.93 ± 21.71 92.60 ± 22.86 54.48 ± 8.27 69.38 ± 17.35
IL-10
153.36 ± 27.01 119.30 ± 29.04 65.05 ± 9.96 100.74 ± 20.97
b
IL-10/TNF-𝛼
1.37 ± 0.027 1.28 ± 0.28 1.19 ± 0.10 1.45 ± 0.67
Data submitted with an average ± EPM. aC-W versus C-CWP; bC-W versus HF-W. (𝑃 < 0.05).
physical, and chemical characteristics vary according to the
procedures used to obtain these proteins. In our study, it was
possible to recover an average OF 30% in WP (Table 2). If
we compare these numbers with published data (which often
use conventional techniques such as ultrafiltration (UF)), our
method seems to be a low efficiency process [19]. However,
cost-benefit considerations should be taken into account. For
example, the UF method is expensive not only in terms of
deployment but also in terms of operation. In addition to
being cost-effective, the coacervation process promotes the
separation of WP and obtains a low-calorie product.
The emergence of food compounds with health ben-
efits may eventually become a good strategy to improve
public health. In recent years, functional food has attracted
the attention from scientific community, consumers, and
food manufacturers. The list of nutraceuticals compounds
(vitamins, probiotics, bioactive peptides, and antioxidants
among others) is extensive, and scientific evidence seems
to increasingly support the concept of health promotion
through food ingredients [20, 21].
Functional foods are usually marketed as food containing
ingredients technologically manipulated to perform a benefit
for health [22]. Our study lends support to previous studies
showing the effectiveness of CWP as a nutraceutical able
to stabilize fat mass gain in animals fed with high fat diet.
Our findings agree with the WP intake benefits extensively
reported in literature [23–27]. As demonstrated, there was
a decrease in body weight in the HF-CWP group when
compared to the HF-W group, accompanied by a reduction
in the adiposity.
It is now well established that excessive consumption of
saturated fat is related to the development of dyslipidemias
[28, 29], and this study further corroborates it, as the animals
fed with high fat diet increased TAG and VLDL. Studies
have demonstrated the insulinotropic effect of WP [9, 11,
30]. In this study, we did not find any significant difference
in blood glucose between the groups assessed. Regarding
insulin and HOMA index, the hyperlipidic diet showed
significantly higher values. Our results demonstrated the
effectiveness of this experimental model of obesity. However,
CWP treatment promoted improved glucose and insulin
tolerance. A study undertaken by Huang et al. [31] utilizing
different protein sources (cheese whey, soy, red meat, and
milk) in obese mice (induced by high fat diet) has found
increased adiponectin concentration and reduced insulin
when the animals were fed with whey protein cheese. In the
present study, we also detected the critical role of CWP in
modulating adiponectin, as the valueswere higher for theHF-
CWP group when compared to HF-W group. These findings
indicate that CWP may have functional effects. Yamauchi et
al. [32] have demonstrated the potential of adiponectin in
reducing insulin resistance by enhancing fatty acid oxidation,
leading to a reduction in TAG content in obese diabetic rats.
There is strong evidence of an immunomodulatory role
ofWP [33]. Products containingWPmay be beneficial in the
treatment of certain diseases. Studies have shown that WP
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promotes improvement in the treatment of gastrointestinal
symptoms of infant mice with rotavirus-induced diarrhea, a
protective role in colorectal cancer in rats, reduced release of
IL-6 in blood of rats undergoing transient ischemia/intestinal
reperfusion andmay provide protective effects against exper-
imentally induced breast cancer in animals [25, 34, 35]. Most
of the more recent studies in the literature, both in vivo and
in vitro, have focused on the possible effects of these proteins
in macrophages and lymphocytes. Although most proteins
are degraded during the gastric digestion, certain cheese
whey proteins, such as 𝛽-Lg, 𝛼-La, or GMP, are resistant
to digestion and remain intact. Such proteins can directly
stimulate leukocyte after their digestive absorption. Thus,
it is important to understand the mechanisms underlying
the impact of these proteins on immunity, stimulating anti-
inflammatory processes in the body [33].
The IL-10 is a pleiotropic cytokine that controls
inflammatory processes by eliminating the proinflammatory
cytokines production such as IL-1, IL-6, and IL-8, and
TNF-𝛼 is produced mainly by monocytes, macrophages,
lymphocytes, mast cells, and mature adipocytes [14, 36].
The IL-10/TNF-𝛼 ratio has been considered an important
indicator of inflammatory status as low values are often
associated with increased morbidity and mortality risk. We
did not observe an increase of the IL-10/TNF-𝛼 ratio in MES
of group HF-CWP. We believe that because of the short
period of the treatment the animals may not have developed
their proinflammatory state. With increased length of
treatment, we believe find results more expressive. Another
possibility is that the coacervate may have protected the mice
from a proinflammatory state triggered by the treatment
diet, leading to the counterbalance of IL-10 unnecessary
in HF-CWP group. However, a study involving a longer
treatment period may be required to discern this possible
effect.
In this sense, there is an immunomodulatory mechanism
underlying CWP, most likely the IL-10 cytokine, which has a
homeostaticmetabolic effect in themesenteric adipose tissue.
Our result suggests that IL-10 may be a positive regulator of
insulin sensitivity and increased glucose uptake.This mecha-
nism can protect the adipose tissue against insulin resistance.
Although the precise origin of the unchecked inflammatory
response in obesity is still unclear, it is well known that
in obesity the overproduction of proinflammatory cytokines
affects metabolism. For example, TNF-𝛼 contributes to the
inability of cells to respond to insulin and to increased
levels of insulin [37], and IL-10 was associated with other
variables closely linked to insulin sensitivity, such as fasting
and postload insulin concentrations, HDL cholesterol, and
triglyceride levels. Besides the tissue-specific effect of CWP,
we showed a systemic effect in the decrease in the LPS serum
level.
Regarding the composition of the CWP, wemay highlight
the presence of 𝛼-La and 𝛽-Lg protein, the major protein
present in the coacervate, which has been proven effective
in suppressing the release of proinflammatory cytokines
[27, 38]. The presence of these proteins is a great indica-
tion that the coacervate components are able to modulate
the proinflammatory milieu promoted by hyperlipidic diet.
In another study by our group, mice, previously treated with
high fat diet and fed with a supplementation of CWP (gavage,
36mg protein/kg of body weight), showed a positive corre-
lation between IL-10 and TNF-alpha in mesenteric adipose
tissue, retroperitoneal adipose tissue, and liver tissue.We also
observed a positive correlation between lipopolysaccharide
and IL-10 in the liver tissue. Therefore, pretreatment with
high fat diet promoted metabolic alterations and inflamma-
tion, and CWP modulated the inflammatory milieu [14].
Evidence suggests that eating WP causes the decrease
in calorie intake, increased basal energy expenditure, and
modulates insulin sensitivity and glucose homeostasis, lead-
ing to changes in lipid metabolism in adipose tissue, liver,
and muscle [39–42]. The AMPK and adiponectin are key
molecules to metabolic responses in different tissues [43,
44]; they are involved in the preventive response against
negative physiological processes caused by the consumption
of a diet high in saturated fatty acids.The activation of AMPK
by bioactive components of foods or medicines has been
regarded as goal, since it may reverse the metabolic changes
associated with obesity and type 2 diabetes [45]. It is also
known that adiponectin can activate AMPK in white adipose
tissue [46]. The animals treated with coacervate showed an
increase in AMPK activation associated with the decrease in
HSL and increase in ATGL protein expression in mesenteric
adipose tissue. Similar results were reported in the review
undertaken by Bijland et al. [47].
A study conducted by Gaidhu et al. [43] showed that
AMPK activation stimulated by AICAR (5-aminoimidazol-4-
carboxamida ribonucleot´ıdeo) initially promoted inhibition of
lipolysis in adipocytes isolated as in vivo, reflecting a decrease
in free fatty acid in serum. On the other hand, prolonged
treatment with AICAR promoted an increase in lipolysis,
which the authors attributed to an increase in the content
of ATGL and reduced activity of HSL [48]. However, clear-
cut conclusions are difficult to arrive at, due to a lack of tools
for manipulating assays using specific AMPK. Furthermore,
the overall effect of AMPK activation of lipolysis is still
controversial.The duration andmode of activation of AMPK
may be of particular importance when it comes to a process
aimed at reducing the proinflammatory state caused by
increased lipolysis [47]. In addition, adiponectin can suppress
the activation of HSL, without changing ATGL and ABHD-5
in adipocytes in order to modulate a homeostatic control of
lipolysis to avoid lipotoxicity [49].
Lipolysis does seem to play a crucial physiological role
by recruiting a source of energy mobilized in times of stress
and/or energy deprivation. Moreover, the very significant
reduction in lipolysis is clearly harmful, as demonstrated
in the clinical domain by the syndromes resulting from
deficiencies in the lipolytic apparatus [50]. Given that, it is
reasonable to question whether the inhibition of lipolysis, via
HSL induced by CWP, is helpful or harmful, since enhanced
lipolytic activity and concomitant increase of free fatty acid
in the circulation is clearly deleterious and leads to several
comorbidities. To clearly determine this, however, an analysis
of free fatty acid and endogenous glycerol concentrations
would need to be carried out.
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Another interesting finding was the significantly higher
protein expression of perilipin A (52%) in HF-W group,
which also refers to larger deposits of triglycerides, since this
protein is primarily anchored around the droplets of neutral
lipids in adipocytes. This is in line with studies showing that
increased protein expression perilipin A leads to increased
storage of triglycerides by reducing its hydrolytic rate. [51].
Finally, there is plenty of evidence suggesting that the
intake of WP may lower consumption of calories, increase
baseline energy expenditure, and improve insulin sensitivity
and glucose homeostasis, thus leading to changes in lipid
metabolism in adipose tissue, liver, and muscle [39–42].
5. Conclusion
CWP were able to promote nutritional and physiological
improvements in HF-CWP group, such as reduction in body
mass and decreased serum lipid levels followed by decreased
serum insulin and LPS. In addition, intervention with CWP
resulted in higher adiponectin contents and attenuated pro-
cesses that would lead to glucose intolerance.Therefore, CWP
could play a beneficial role, in some way, in modulating
lipolysis in animals treated with hyperlipidic diet.
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